Female Infertility Industry Data Book Covers In Vitro Fertilization (IVF) and Artificial Insemination Markets.
The global female infertility market size was valued at USD 25.7 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.97% from 2023 to 2030.
Access the Global Female Infertility Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies.
In Vitro Fertilization Market Growth & Trends
The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.72% from 2023 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. The expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact market growth in the near future.
Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.
A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, postponement of marriage, an increasing number of women employees, and lower marriage rates. In March 2020, in-person fertility treatments in U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resuming in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics and Gynecology journal, in January 2022 reported COVID-19 vaccines won't harm IVF outcomes. This is expected to prove significant in promoting the uptake of IVF in eligible vaccinated individuals.
Order your copy of Free Sample of “Female Infertility Industry Data Book - In Vitro Fertilization (IVF) and Artificial Insemination Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Artificial Insemination Market Growth & Trends
The global artificial insemination market size is expected to reach USD 2.9 billion by 2026 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.
Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).
Go through the table of content of Female Infertility Industry Data Book to get a better understanding of the Coverage & Scope of the study.
Competitive Landscape
Key players operating in the Female Infertility Industry are –
• Ferring B.V.
• Vitrolife AB
• CooperSurgical, Inc.
• Cosmos Biomedical Ltd.
• Merck KGaA
• Cryolab Ltd.
• FUJIFILM Irvine Scientific
• Bloom IVF Centre
• Microm UK Ltd.
• OvaScience
• Irvine Scientific
• Progyny, Inc.
• EMD Serono Inc.
• Thermo Fisher Scientific Inc.
• Boston IVF
Grand View Research’s Female Infertility industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
Check out more Industry Data Books, published by Grand View Research
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
No comments:
Post a Comment